Kazia Therapeutics Limited (KZIA)

Kazia Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	3.06	1.66	5.24	7.36	27.59	8.76
Cash & Short-Term Investments	3.06	1.66	5.24	7.36	27.59	8.76
Cash Growth	-13.99%	-68.38%	-28.80%	-73.32%	214.77%	61.28%
Accounts Receivable	-	-	0	-	-	0
Other Receivables	0.09	0.13	0.1	0.05	0.08	1.19
Receivables	0.09	0.13	0.11	0.05	0.08	1.19
Prepaid Expenses	0.25	0.59	1.63	2	1.72	0.54
Other Current Assets	0.01	3.76	3.79	0.04	0.01	0.16
Total Current Assets	3.41	6.15	10.77	9.45	29.39	10.65
Other Intangible Assets	14.47	15.4	17.27	19.14	22	12.41
Other Long-Term Assets	0.04	0.04	0.04	7.3	6.69	-
Total Assets	17.91	21.59	28.08	35.89	58.09	23.06
Accounts Payable	6.33	4.55	0.86	1.52	1.89	1.69
Accrued Expenses	4.51	10.88	4.16	2.6	3.27	1.99
Short-Term Debt	0.14	0.63	1.8	1.84	-	-
Other Current Liabilities	5.53	9.73	0.75	0.76	3.16	1.39
Total Current Liabilities	16.51	25.8	7.57	6.73	8.33	5.07
Long-Term Deferred Tax Liabilities	1.88	2.02	2.29	2.56	2.93	3.41
Other Long-Term Liabilities	3.29	3.75	6.12	8.21	8.93	0.46
Total Liabilities	21.72	31.6	16.03	17.61	20.24	8.94
Common Stock	117.46	101.64	97.45	84.48	80.29	48.78
Retained Earnings	-125.09	-115.13	-89.08	-68.62	-44.2	-36.19
Comprehensive Income & Other	3.82	3.48	3.68	2.41	1.76	1.53
Total Common Equity	-3.81	-10.02	12.05	18.27	37.85	14.13
Shareholders' Equity	-3.81	-10.02	12.05	18.27	37.85	14.13
Total Liabilities & Equity	17.91	21.59	28.08	35.89	58.09	23.06
Total Debt	0.14	0.63	1.8	1.84	-	-
Net Cash (Debt)	2.92	1.02	3.45	5.52	27.59	8.76
Net Cash Growth	-8.73%	-70.30%	-37.59%	-79.99%	214.77%	61.28%
Net Cash Per Share	4.10	1.94	9.35	20.84	117.22	59.98
Filing Date Shares Outstanding	0.97	0.87	0.47	0.3	0.26	0.19
Total Common Shares Outstanding	0.97	0.67	0.46	0.28	0.26	0.19
Working Capital	-13.11	-19.65	3.21	2.72	21.06	5.59
Book Value Per Share	-3.94	-15.05	26.42	65.85	143.36	74.66
Tangible Book Value	-18.27	-25.42	-5.22	-0.86	15.85	1.72
Tangible Book Value Per Share	-18.90	-38.18	-11.44	-3.11	60.03	9.07

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q